{"transactions":[{"id":972113,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-12-13T01:08:14.000Z","date":"2025-12-12","kind":"grant","planned":false,"acquired":true,"shares":612,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on June 16, 2025. This RSU award, which was granted effective December 12, 2025 and had an aggregate fair market value of approximately $125,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on June 16, 2025. This RSU award, which was granted effective December 12, 2025 and had an aggregate fair market value of approximately $125,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents fully vested RSUs treated as common stock equivalents (adjusted downward by 7 due to last year's grant erroneously reported as 412 instead of 405). Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."}],"balance_after":2503,"source":{"system":"sec-edgar","filing":"0000105132-25-000122","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513225000122/form4.xml","form_type":"4"}},{"id":1331622,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-12-16T21:16:29.000Z","date":"2024-12-12","kind":"grant","planned":false,"acquired":true,"shares":412,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on October 3, 2024.  This RSU award, which was granted effective December 12, 2024 and had an aggregate fair market value of approximately $110,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with Issuer's Directors' Compensation Policy and Election Plan adopted on October 3, 2024.  This RSU award, which was granted effective December 12, 2024 and had an aggregate fair market value of approximately $110,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."}],"balance_after":1898,"source":{"system":"sec-edgar","filing":"0000105132-24-000106","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513224000106/form4.xml","form_type":"4"}},{"id":1713255,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-12-13T14:24:22.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":true,"shares":406,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with the Issuer's Directors' Compensation Policy and Election Plan adopted on October 5, 2023.  This RSU award, which was granted effective December 12, 2023 and had an aggregate fair market value of approximately $97,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with the Issuer's Directors' Compensation Policy and Election Plan adopted on October 5, 2023.  This RSU award, which was granted effective December 12, 2023 and had an aggregate fair market value of approximately $97,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."}],"balance_after":1486,"source":{"system":"sec-edgar","filing":"0000105132-23-000101","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000010513223000101/form4.xml","form_type":"4"}},{"id":2087208,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T00:30:59.000Z","date":"2022-12-13","kind":"grant","acquired":true,"shares":480,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a restricted stock unit (\"RSU\") award covering shares of Issuer's common stock granted in accordance with the Issuer's Directors' Compensation Policy and Election Plan adopted on October 12, 2021.  This RSU award, which was granted effective December 13, 2022 and had an aggregate fair market value of approximately $80,000 on such date, is the non-elective portion of annual director compensation and vests upon grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents fully vested RSUs treated as common stock equivalents.  Following termination of the Reporting Person's service as a director, the RSUs will be settled with Issuer's common stock."}],"balance_after":1080,"source":{"system":"sec-edgar","filing":"0001567619-22-021607","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000156761922021607/doc1.xml","form_type":"4"}},{"id":2207469,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-14T20:36:29.000Z","date":"2022-07-12","kind":"exercise","acquired":false,"shares":167812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represented a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"shares","element":"transactionShares","label":"F5","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Any unvested restricted stock units vested completely immediately prior to the Merger, and the underlying shares were delivered to the Reporting Person immediately prior to the Merger in accordance with the terms of the grants."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":167812},"source":{"system":"sec-edgar","filing":"0001209191-22-042203","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042203/doc4.xml","form_type":"4"}},{"id":2207468,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-14T20:36:29.000Z","date":"2022-07-12","kind":"disposition_to_issuer","acquired":false,"shares":167812,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Disposed of pursuant to the Merger Agreement in exchange for 14,767 Ordinary Shares of BIOX having a market value of $9.44 per share on the effective date of the Merger."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-22-042203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042203/doc4.xml","form_type":"4"}},{"id":2207467,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-07-14T20:36:29.000Z","date":"2022-07-12","kind":"grant","acquired":true,"shares":167812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Any unvested restricted stock units became vested and all restricted stock units were delivered to the Reporting Person, pursuant to the grant terms, immediately prior to the change of control transaction (the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 16, 2022, by and between Bioceres Crop Solutions Corp., BCS Merger Sub, Inc., and Issuer (the \"Merger Agreement\")."},{"field":"shares","element":"transactionShares","label":"F2","text":"The settlement of restricted stock units is being reported as one award; however, a number of awards of restricted stock units, as reported in prior Forms 4, are being settled. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, details of the awards previously granted and settled as set forth in this footnote to this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Any unvested restricted stock units became vested and all restricted stock units were delivered to the Reporting Person, pursuant to the grant terms, immediately prior to the change of control transaction (the \"Merger\") contemplated by the Agreement and Plan of Merger, dated as of March 16, 2022, by and between Bioceres Crop Solutions Corp., BCS Merger Sub, Inc., and Issuer (the \"Merger Agreement\")."}],"balance_after":167812,"source":{"system":"sec-edgar","filing":"0001209191-22-042203","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122042203/doc4.xml","form_type":"4"}},{"id":2214545,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-07-05T16:20:35.000Z","date":"2022-06-30","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on June 30, 2022. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on June 30, 2022. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001209191-22-040654","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122040654/doc4.xml","form_type":"4"}},{"id":2300164,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-08T16:06:50.000Z","date":"2022-04-06","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock units granted as compensation for serving on the board vest with respect to 100% of the total shares on April 6, 2023, with pro rata vesting based on days elapsed since grant in event of a change in control event prior to that date. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted stock units granted as compensation for serving on the board vest with respect to 100% of the total shares on April 6, 2023, with pro rata vesting based on days elapsed since grant in event of a change in control event prior to that date. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":25000,"derivative":{"underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001209191-22-023839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122023839/doc4.xml","form_type":"4"}},{"id":2300163,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-04-08T16:06:50.000Z","date":"2022-04-06","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock units granted as compensation for serving on committees vest with respect to 100% of the total shares subject to the grant on April 6, 2022. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted stock units granted as compensation for serving on committees vest with respect to 100% of the total shares subject to the grant on April 6, 2022. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001209191-22-023839","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122023839/doc4.xml","form_type":"4"}},{"id":2448788,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-01-04T16:12:48.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on December 31, 2021. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on December 31, 2021. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001209191-22-000685","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919122000685/doc4.xml","form_type":"4"}},{"id":2472446,"issuer":{"id":4262,"kind":"organization","name":"WD 40 CO","symbol":"WDFC"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-16T01:06:13.000Z","date":"2021-12-14","kind":"grant","acquired":true,"shares":332,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted Stock Units (Common Stock equivalents) were granted pursuant to the WD-40 Company 2016 Stock Incentive Plan for a non-elective portion of annual director compensation in accordance with the Issuer's Directors' Compensation Policy and Election Plan. The Restricted Stock Units will be settled solely with Issuer Common Stock upon termination of the reporting person's service as a director."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (Common Stock equivalents) were granted pursuant to the WD-40 Company 2016 Stock Incentive Plan for a non-elective portion of annual director compensation in accordance with the Issuer's Directors' Compensation Policy and Election Plan. The Restricted Stock Units will be settled solely with Issuer Common Stock upon termination of the reporting person's service as a director."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Total represents 600 Restricted Stock Units (Common Stock equivalents)."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001567619-21-022123","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105132/000156761921022123/doc1.xml","form_type":"4"}},{"id":2551884,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-10-04T17:31:24.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on September 30, 2021. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on September 30, 2021. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001209191-21-059086","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121059086/doc4.xml","form_type":"4"}},{"id":2641033,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-07-06T16:46:54.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on June 30, 2021.  Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on June 30, 2021.  Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001209191-21-045518","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121045518/doc4.xml","form_type":"4"}},{"id":2691108,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-05-28T17:41:09.000Z","date":"2021-05-26","kind":"grant","acquired":true,"shares":17076,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on May 26, 2022. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on May 26, 2022. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":17076,"derivative":{"underlying":"Common Stock","underlying_shares":17076},"source":{"system":"sec-edgar","filing":"0001209191-21-036601","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121036601/doc4.xml","form_type":"4"}},{"id":2761075,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-04-02T18:39:41.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":10625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on March 31, 2021.  Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on March 31, 2021.  Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":10625,"derivative":{"underlying":"Common Stock","underlying_shares":10625},"source":{"system":"sec-edgar","filing":"0001209191-21-024795","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121024795/doc4.xml","form_type":"4"}},{"id":2925463,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-01-04T17:06:34.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":6929,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on December 31, 2020. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on December 31, 2020. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":6929,"derivative":{"underlying":"Common Stock","underlying_shares":6929},"source":{"system":"sec-edgar","filing":"0001209191-21-000342","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919121000342/doc4.xml","form_type":"4"}},{"id":2992602,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-11-04T17:44:21.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":12432,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on May 31, 2021. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest with respect to 100% of the total shares subject to the grant on May 31, 2021. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":12432,"derivative":{"underlying":"Common Stock","underlying_shares":12432},"source":{"system":"sec-edgar","filing":"0001209191-20-056958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120056958/doc4.xml","form_type":"4"}},{"id":2992601,"issuer":{"id":125354,"kind":"organization","name":"MARRONE BIO INNOVATIONS INC","symbol":"MBII"},"owners":[{"id":71747,"kind":"person","name":"Lee Lara L","position":1,"cik":"0001830288","reported_name":"Lee Lara L","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-11-04T17:44:21.000Z","date":"2020-11-02","kind":"grant","acquired":true,"shares":42625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Marrone Bio Innovations, Inc. common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested with respect to 1/3rd of the total shares on the first anniversary of the vesting commencement date of November 2, 2020, and with respect to 1/24th of the remaining shares subject to the grant monthly thereafter for 24 months. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested with respect to 1/3rd of the total shares on the first anniversary of the vesting commencement date of November 2, 2020, and with respect to 1/24th of the remaining shares subject to the grant monthly thereafter for 24 months. Vested shares will be delivered to the reporting person upon the earlier of the reporting person's separation of service with the Company or immediately prior to a change in control event."}],"balance_after":42625,"derivative":{"underlying":"Common Stock","underlying_shares":42625},"source":{"system":"sec-edgar","filing":"0001209191-20-056958","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1441693/000120919120056958/doc4.xml","form_type":"4"}}]}